These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 36703939)

  • 21. MYH16 upregulation is associated with lung adenocarcinoma aggressiveness and immune infiltration.
    Zhang L; Liu J; Wang H; Xu Z; Wang Y; Chen Y; Peng H
    J Biochem Mol Toxicol; 2023 Dec; 37(12):e23490. PubMed ID: 37589445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TCN1 is a potential prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma.
    Li H; Guo L; Cai Z
    World J Surg Oncol; 2022 Mar; 20(1):83. PubMed ID: 35287670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MRPL12 Acts as A Novel Prognostic Biomarker Involved in Immune Cell Infiltration and Tumor Progression of Lung Adenocarcinoma.
    Hu Y; Liu Y; Ma C; Ai K
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High Expression of
    Chen Y; Zhou M; Gu X; Wang L; Wang C
    Dis Markers; 2022; 2022():8789515. PubMed ID: 35855850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TEDC2 correlated with prognosis and immune microenvironment in lung adenocarcinoma.
    Fang L; Yu W; Zhu P; Yu G; Ye B
    Sci Rep; 2023 Mar; 13(1):5006. PubMed ID: 36973475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The High Expression of PTPRH Is Associated with Poor Prognosis of Human Lung Adenocarcinoma.
    Chen A; Ding S; Shen X; Lin X
    Comput Math Methods Med; 2021; 2021():9932088. PubMed ID: 34367321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.
    Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ
    Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of the Prognostic Value of STEAP1 in Lung Adenocarcinoma and Insights Into Its Potential Molecular Pathways via Bioinformatic Analysis.
    Guo Q; Ke XX; Liu Z; Gao WL; Fang SX; Chen C; Song YX; Han H; Lu HL; Xu G
    Front Genet; 2020; 11():242. PubMed ID: 32265985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSC.
    Fu L; Wang H; Wei D; Wang B; Zhang C; Zhu T; Ma Z; Li Z; Wu Y; Yu G
    PLoS One; 2020; 15(5):e0233283. PubMed ID: 32437446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
    Wu P; Zheng Y; Wang Y; Wang Y; Liang N
    J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear protein NOP2 serves as a poor-prognosis predictor of LUAD and aggravates the malignancy of lung adenocarcinoma cells.
    Qin W; Fei G; Zhou Q; Li Z; Li W; Wei P
    Funct Integr Genomics; 2024 Mar; 24(2):58. PubMed ID: 38489049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Independent Prognostic Potential of GNPNAT1 in Lung Adenocarcinoma.
    Zheng X; Li Y; Ma C; Zhang J; Zhang Y; Fu Z; Luo H
    Biomed Res Int; 2020; 2020():8851437. PubMed ID: 33178836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In silico analysis reveals PRR11 as a prognostic and oncogenic marker in lung adenocarcinoma.
    Hu A; Tang K; Liu J; Han X; Chen Q
    Medicine (Baltimore); 2023 May; 102(21):e33755. PubMed ID: 37233443
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Wang FM; Xu LQ; Zhang ZC; Guo Q; Du ZP; Lei Y; Han X; Wu CY; Zhao F; Chen JL
    Aging (Albany NY); 2024 Jan; 16(2):1605-1619. PubMed ID: 38244585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioinformatics Analysis and Experimental Study of Exonuclease 1 Gene in Lung Adenocarcinoma.
    Wang S; Cai W; Li J; An W; Zheng H; Liao M
    Biochem Genet; 2022 Dec; 60(6):1934-1945. PubMed ID: 35169964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High Expression of
    Deng H; Huang Y; Wang L; Chen M
    Biomed Res Int; 2020; 2020():2071593. PubMed ID: 33134373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of radiotherapy-related autophagy genes in the prognosis and immune infiltration in lung adenocarcinoma.
    Gao J; Lu F; Yan J; Wang R; Xia Y; Wang L; Li L; Chang L; Li W
    Front Immunol; 2022; 13():992626. PubMed ID: 36311724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The low expression of NUP62CL indicates good prognosis and high level of immune infiltration in lung adenocarcinoma.
    Ren S; Wang W; Zhang C; Sun Y; Sun M; Wang Y; Zhang X; Lu B; Yao L
    Cancer Med; 2021 May; 10(10):3403-3412. PubMed ID: 33934535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pan-cancer analysis identifies
    Yang H; Wei X; Zhang L; Xiang L; Wang P
    Transl Cancer Res; 2022 Aug; 11(8):2902-2916. PubMed ID: 36093552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinoma.
    Wang Y; Xu J; Fang Y; Gu J; Zhao F; Tang Y; Xu R; Zhang B; Wu J; Fang Z; Li Y
    Front Immunol; 2022; 13():950001. PubMed ID: 36091041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.